Please login to the form below
Kim Lemon appointed head of Liberation Unlimited
Will lead rebrand of Communiqué award-winning agency
Liberation Unlimited has named former associate director Kim Lemon as its new head.
The announcement comes a few weeks after Liberation Communications changed its name to Liberation Unlimited as part of a rebrand of its parent group Creston Health, which is now known as Health Unlimited.
Lemon spent five years as associate director at Liberation having joined the company in 2009 from Athena Medical PR where she served as senior account manager. She also has experience in industry at the Johnson & Johnson subsidiary Lifescan.
Catherine Warne, CEO of Health Unlimited said: “Over the last year, and particularly in the last five months, Kim has become a figurehead for the agency.
“She has taken the lead on the development of a strong business plan for the agency, the roll-out of Liberation Unlimited and completely fresh branding, which will be launched in the New Year.”
During her time at Liberation Lemon helped the agency to the Small Consultancy or Health Team of the Year award at the 2014 Communiqué Awards. She also led the PR team that won the Cello Health Award for Launch Excellence at the recent PMEA for its work on Bayer's Eylea.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Pfizer’s RSV vaccine approved by FDA for older adults
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
- Innovative Trials responds to national recommendations to tackle UK clinical trial decline
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Tuberculosis – why it remains a major global public health challenge
No results were found
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
